An improved method for semiquantification of gene amplification from archival material

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• The C-erbB-2 gene is frequently amplified in various human adenocarcinomas, including breast, lung, and stomach cancers.
• Elevated C-erbB-2 gene copy number is often associated with a poorer prognosis in cancer patients.
• Accurate quantification of C-erbB-2 gene amplification is crucial for stratifying patients and predicting clinical outcomes.

Purpose of the Study:

• To develop and validate a highly accurate differential PCR-based assay for quantifying C-erbB-2 gene copy number.
• To assess the utility of this assay for analyzing DNA extracted from archival tumor samples, including paraffin-embedded tissues.

Main Methods:

• A differential PCR assay was designed to coamplify the target C-erbB-2 gene and a single-copy reference gene within the same reaction tube.
• The ratio of PCR product yields was used to reflect the level of C-erbB-2 gene amplification.
• Cell lines with known C-erbB-2 gene copy numbers (ranging from 1 to >8) were employed as quality controls.

Main Results:

• The developed assay demonstrated high accuracy in quantifying C-erbB-2 gene copy number.
• The technique reliably detected even single-copy differences between cell lines.
• Semi-quantitative estimation of gene copy number in DNA from archival paraffin-embedded samples was achievable.

Conclusions:

• The differential PCR assay provides an accurate and reliable method for quantifying C-erbB-2 gene copy number in archival tumor DNA.
• This assay has the potential to improve patient stratification and clinical outcome prediction in cancers with C-erbB-2 amplification.
• The technique's ability to analyze archival samples makes it valuable for retrospective studies in oncology.